Abbi E. Smith

465 total citations
14 papers, 162 citations indexed

About

Abbi E. Smith is a scholar working on Neurology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Abbi E. Smith has authored 14 papers receiving a total of 162 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Neurology, 5 papers in Molecular Biology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Abbi E. Smith's work include Neurofibromatosis and Schwannoma Cases (11 papers), Sarcoma Diagnosis and Treatment (4 papers) and Meningioma and schwannoma management (3 papers). Abbi E. Smith is often cited by papers focused on Neurofibromatosis and Schwannoma Cases (11 papers), Sarcoma Diagnosis and Treatment (4 papers) and Meningioma and schwannoma management (3 papers). Abbi E. Smith collaborates with scholars based in United States, United Kingdom and Australia. Abbi E. Smith's co-authors include D. Wade Clapp, Waylan Bessler, Steven D. Rhodes, Qingbo Lu, Adam R. Smith, Christopher M. Hofmann, Eirı́kur Steingrı́msson, N. Justin Marshall, Yongzheng He and George E. Sandusky and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Human Molecular Genetics.

In The Last Decade

Abbi E. Smith

14 papers receiving 161 citations

Peers

Countries citing papers authored by Abbi E. Smith

Since Specialization

Citations

This map shows the geographic impact of Abbi E. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abbi E. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abbi E. Smith more than expected).

Fields of papers citing papers by Abbi E. Smith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abbi E. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abbi E. Smith. The network helps show where Abbi E. Smith may publish in the future.

Co-authorship network of co-authors of Abbi E. Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Abbi E. Smith. A scholar is included among the top collaborators of Abbi E. Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abbi E. Smith. Abbi E. Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	A haploinsufficiency restoration strategy corrects neurobehavioral deficits in Nf1+/– mice 2025 ·Journal of Clinical Investigation ·(unknown), Jodi L. Lukkes, (unknown), (unknown), (unknown), (unknown), M. Sullivan, (unknown), Nathan Cunningham, (unknown), Michael A. Collins, Jacob Zucker, Jungyeon Won, Abbi E. Smith, Li Jiang, (unknown), Steven D. Rhodes, Steven P. Angus, D. Wade Clapp	1
2	TGFβ-dependent signaling drives tumor growth and aberrant extracellular matrix dynamics in NF1-associated plexiform neurofibroma 2025 ·Science Advances ·(unknown), Zhuan Zhou, Chunhui Jiang, (unknown), Waylan Bessler, (unknown), Xiaohong Li, (unknown), Abbi E. Smith, Henry Mang, (unknown), (unknown), (unknown), (unknown), George E. Sandusky, Andrea R. Masters, Steven P. Angus, D. Wade Clapp, Lu Q. Le, Steven D. Rhodes	1
3	Hedgehog signalling in bone and osteoarthritis: the role of Smoothened and cholesterol 2022 ·FEBS Journal ·Abbi E. Smith, (unknown), Eirı́kur Steingrı́msson, Sara Sigurbjörnsdóttir	19
4	Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours 2021 ·British Journal of Cancer ·Silpa Gampala, Fenil Shah, Chi Zhang, Steven D. Rhodes, (unknown), (unknown), (unknown), (unknown), Brian L. Calver, Ren-Yuan Bai, Verena Staedtke, (unknown), M. Reza Saadatzadeh, Karen E. Pollok, Yan Tong, Abbi E. Smith, D. Wade Clapp, Andrew R. Tee, Mark R. Kelley, Melissa L. Fishel	10
5	Irradiation of Nf1 mutant mouse models of spinal plexiform neurofibromas drives pathologic progression and decreases survival 2021 ·Neuro-Oncology Advances ·(unknown), Abbi E. Smith, Waylan Bessler, Marc S. Mendonca, Helen Chin-Sinex, Martina Descovich, Andrew Horvai, D. Wade Clapp, Jean L. Nakamura	3
6	PAK1 inhibition reduces tumor size and extends the lifespan of mice in a genetically engineered mouse model of Neurofibromatosis Type 2 (NF2) 2021 ·Human Molecular Genetics ·(unknown), (unknown), (unknown), (unknown), Daniela Araiza‐Olivera, Maria Radu, Abbi E. Smith, (unknown), Li Jiang, Xiaohong Li, Waylan Bessler, Andrea R. Masters, Donna M. Edwards, (unknown), David Jones, Charles W. Yates, D. Wade Clapp, Jonathan Chernoff, Su-Jung Park	14
7	Cleveland Clinic International IV Robotics Summit 2021 ·American Journal of Health-System Pharmacy ·(unknown), (unknown), Ahmed Al‐Jedai, (unknown), Michael Cotugno, (unknown), John Fanikos, (unknown), (unknown), (unknown), Abbi E. Smith, (unknown), (unknown), (unknown), Scott J. Knoer	2
8	Genetic disruption of the small GTPase RAC1 prevents plexiform neurofibroma formation in mice with neurofibromatosis type 17 2020 ·Journal of Biological Chemistry ·Julie A. Mund, (unknown), Abbi E. Smith, Yongzheng He, Li Jiang, (unknown), (unknown), (unknown), (unknown), Jin Yuan, Waylan Bessler, George E. Sandusky, Shi Chen, Chi Zhang, Steven D. Rhodes, D. Wade Clapp	6
9	Early administration of imatinib mesylate reduces plexiform neurofibroma tumor burden with durable results after drug discontinuation in a mouse model of neurofibromatosis type 1 2020 ·Pediatric Blood & Cancer ·Amy E. Armstrong, Steven D. Rhodes, Abbi E. Smith, Shi Chen, Waylan Bessler, Michael J. Ferguson, Jiang Li, Xiaohong Li, Jin Yuan, Xianlin Yang, Feng‐Chun Yang, Kent A. Robertson, David A. Ingram, Jaishri O. Blakeley, D. Wade Clapp	1
10	Ketotifen Modulates Mast Cell Chemotaxis to Kit-Ligand, but Does Not Impact Mast Cell Numbers, Degranulation, or Tumor Behavior in Neurofibromas of Nf1-Deficient Mice 2019 ·PMC ·(unknown), Steven D. Rhodes, Waylan Bessler, Shi Chen, Abbi E. Smith, (unknown), (unknown), Jiang Li, Xiaohong Li, Jin Yuan, Qingbo Lu, Max Jacobsen, George E. Sandusky, David R. Jones, D. Wade Clapp, Jaishri O. Blakeley	2
11	Ketotifen Modulates Mast Cell Chemotaxis to Kit-Ligand, but Does Not Impact Mast Cell Numbers, Degranulation, or Tumor Behavior in Neurofibromas of Nf1-Deficient Mice 2019 ·Molecular Cancer Therapeutics ·(unknown), Steven D. Rhodes, Waylan Bessler, Shi Chen, Abbi E. Smith, (unknown), (unknown), Jiang Li, Xiaohong Li, Jin Yuan, Qingbo Lu, Max Jacobsen, George E. Sandusky, David R. Jones, D. Wade Clapp, Jaishri O. Blakeley	10
12	Cdkn2a (Arf) loss drives NF1-associated atypical neurofibroma and malignant transformation 2019 ·Human Molecular Genetics ·Steven D. Rhodes, Yongzheng He, Abbi E. Smith, Jiang Li, Qingbo Lu, Julie A. Mund, Xiaohong Li, Waylan Bessler, (unknown), William E. Dyer, George E. Sandusky, Andrew Horvai, Amy E. Armstrong, D. Wade Clapp	55
13	Chemopreventative celecoxib fails to prevent schwannoma formation or sensorineural hearing loss in genetically engineered murine model of neurofibromatosis type 2 2017 ·Oncotarget ·(unknown), (unknown), Yongzheng He, Abbi E. Smith, Jin Yuan, (unknown), David R. Jones, (unknown), Su-Jung Park, Simon J. Conway, D. Wade Clapp, Charles W. Yates	6
14	Intraspecific cone opsin expression variation in the cichlids of Lake Malawi 2010 ·Molecular Ecology ·Adam R. Smith, (unknown), Abbi E. Smith, (unknown), Christopher M. Hofmann, N. Justin Marshall, Karen L. Carleton	32

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact